Search research articles
Contact Us
Filters
Showing results (151-160 of 276) with videos related to
Page
of 28
Sort By:
Leukemia Research
|
August 19, 2003
Phase II study of troxacitabine, a novel dioxolane nucleoside analog, in patients with untreated or imatinib mesylate-resistant chronic myelogenous leukemia in blastic phase
Francis J Giles, Eric J Feldman, Gail J Roboz, et al.
Nature Communications
|
April 28, 2022
Allogeneic TCRαβ deficient CAR T-cells targeting CD123 in acute myeloid leukemia
Mayumi Sugita, Roman Galetto, Hongliang Zong, et al.
Antimicrobial Agents and Chemotherapy
|
June 26, 2026
Colonization with extended-spectrum and AmpC β-lactamase-producing Enterobacterales and bacteremia risk in patients with acute leukemia who receive induction chemotherapy without fluoroquinolone prophylaxis
Kate Stoeckle, Ivo Sah Bandar, Liang Chen, et al.
Blood
|
May 27, 2011
Phase 1 study of epigenetic priming with decitabine prior to standard induction chemotherapy for patients with AML
Joseph M Scandura, Gail J Roboz, Michelle Moh, et al.
Molecular Cancer Therapeutics
|
June 18, 2014
Selective activity of the histone deacetylase inhibitor AR-42 against leukemia stem cells: a novel potential strategy in acute myelogenous leukemia
Monica L Guzman, Neng Yang, Krishan K Sharma, et al.
Future Oncology (London, England)
|
January 20, 2016
Design of the randomized, Phase III, QUAZAR AML Maintenance trial of CC-486 (oral azacitidine) maintenance therapy in acute myeloid leukemia
Gail J Roboz, Pau Montesinos, Dominik Selleslag, et al.
Haematologica
|
November 9, 2014
A phase 1b/2 study of vosaroxin in combination with cytarabine in patients with relapsed or refractory acute myeloid leukemia
Jeffrey E Lancet, Gail J Roboz, Larry D Cripe, et al.
Blood
|
September 10, 2020
BCL6 maintains survival and self-renewal of primary human acute myeloid leukemia cells
Kimihito C Kawabata, Hongliang Zong, Cem Meydan, et al.
Transplantation and Cellular Therapy
|
September 7, 2024
Transplant Outcomes in Myelofibrosis: Impact of Donor Type (Cord Blood Grafts Supported by CD34+ selected Cells [Haplo-Cord] Versus Matched Donors)
Nima Ghalehsari, Franco Castillo Tokumori, Zhengming Chen, et al.
Leukemia & Lymphoma
|
August 25, 2012
Emergence of carbapenem-resistant Enterobacteriaceae as causes of bloodstream infections in patients with hematologic malignancies
Michael J Satlin, David P Calfee, Liang Chen, et al.
Page
of 28
Search research articles
Search
Showing results (151-160 of 276) with videos related to
Sort By:
Page
of 28
Leukemia Research
|
August 19, 2003
Phase II study of troxacitabine, a novel dioxolane nucleoside analog, in patients with untreated or imatinib mesylate-resistant chronic myelogenous leukemia in blastic phase
Francis J Giles, Eric J Feldman, Gail J Roboz, et al.
Nature Communications
|
April 28, 2022
Allogeneic TCRαβ deficient CAR T-cells targeting CD123 in acute myeloid leukemia
Mayumi Sugita, Roman Galetto, Hongliang Zong, et al.
Antimicrobial Agents and Chemotherapy
|
June 26, 2026
Colonization with extended-spectrum and AmpC β-lactamase-producing Enterobacterales and bacteremia risk in patients with acute leukemia who receive induction chemotherapy without fluoroquinolone prophylaxis
Kate Stoeckle, Ivo Sah Bandar, Liang Chen, et al.
Blood
|
May 27, 2011
Phase 1 study of epigenetic priming with decitabine prior to standard induction chemotherapy for patients with AML
Joseph M Scandura, Gail J Roboz, Michelle Moh, et al.
Molecular Cancer Therapeutics
|
June 18, 2014
Selective activity of the histone deacetylase inhibitor AR-42 against leukemia stem cells: a novel potential strategy in acute myelogenous leukemia
Monica L Guzman, Neng Yang, Krishan K Sharma, et al.
Future Oncology (London, England)
|
January 20, 2016
Design of the randomized, Phase III, QUAZAR AML Maintenance trial of CC-486 (oral azacitidine) maintenance therapy in acute myeloid leukemia
Gail J Roboz, Pau Montesinos, Dominik Selleslag, et al.
Haematologica
|
November 9, 2014
A phase 1b/2 study of vosaroxin in combination with cytarabine in patients with relapsed or refractory acute myeloid leukemia
Jeffrey E Lancet, Gail J Roboz, Larry D Cripe, et al.
Blood
|
September 10, 2020
BCL6 maintains survival and self-renewal of primary human acute myeloid leukemia cells
Kimihito C Kawabata, Hongliang Zong, Cem Meydan, et al.
Transplantation and Cellular Therapy
|
September 7, 2024
Transplant Outcomes in Myelofibrosis: Impact of Donor Type (Cord Blood Grafts Supported by CD34+ selected Cells [Haplo-Cord] Versus Matched Donors)
Nima Ghalehsari, Franco Castillo Tokumori, Zhengming Chen, et al.
Leukemia & Lymphoma
|
August 25, 2012
Emergence of carbapenem-resistant Enterobacteriaceae as causes of bloodstream infections in patients with hematologic malignancies
Michael J Satlin, David P Calfee, Liang Chen, et al.
Page
of 28